Effects of intramuscular administration of low doses of medetomidine and medetomidine-butorphanol in middle-aged and old dogs

William W. Muir III From the Section of Anesthesia, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210.

Search for other papers by William W. Muir III in
Current site
Google Scholar
PubMed
Close
 DVM, PhD, DACVA, DACVECC
,
Jennifer L. Ford From the Section of Anesthesia, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210.

Search for other papers by Jennifer L. Ford in
Current site
Google Scholar
PubMed
Close
,
Gladys E. Karpa From the Section of Anesthesia, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210.

Search for other papers by Gladys E. Karpa in
Current site
Google Scholar
PubMed
Close
,
Earl E. Harrison From the Section of Anesthesia, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210.

Search for other papers by Earl E. Harrison in
Current site
Google Scholar
PubMed
Close
 BS
, and
Jennifer E. Gadawski From the Section of Anesthesia, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210.

Search for other papers by Jennifer E. Gadawski in
Current site
Google Scholar
PubMed
Close

Click on author name to view affiliation information

Objective

To determine effects of low doses of medetomidine administered with and without butorphanol and glycopyrrolate to middle-aged and old dogs.

Design

Prospective randomized clinical trial.

Animals

88 healthy dogs ≥ 5 years old.

Procedure

Dogs were assigned randomly to receive medetomidine (2, 5, or 10 pa/kg [0.9, 2.3, or 4.6 μg/lb] of body weight, IM) alone or with glycopyrrolate (0.01 mg/kg [0.005 mg/Ib], SC), medetomidine (10 μg/kg) and butorphanol (0.2 mg/kg [0.1 mg/lb], IM), or medetomidine (10 μg/kg), butorphanol (0.2 mg/kg), and glycopyrrolate (0.01 mg/kg). Anesthesia was induced with thiopental sodium and maintained with isoflurane. Degree of sedation and analgesia were determined before and after medetomidine administration. Respiratory rate, heart rate, and mean arterial blood pressure were determined 10 and 30 minutes after medetomidine administration. Adverse effects and amounts of thiopental and isoflurane used were recorded.

Results

Sedation increased after medetomidine administration in 79 of 88 dogs, but decreased in 7 dogs that received 2 or 5 μg of medetomidine/kg. Mean postsedation analgesia score and amounts of thiopental and isoflurane used were less in dogs that received medetomidine and butorphanol, compared with other groups. Respiratory rate, heart rate, and blood pressure were not different among groups. Significantly more adverse effects developed in dogs that did not receive glycopyrrolate.

Conclusions and Clinical Relevance

Administration of medetomidine (10 μg/kg, IM) and butorphanol (0.2 mg/kg, IM) induced sedation and analgesia and reduced amounts of thiopental and isoflurane required for anesthesia in middle-aged and old dogs. Glycopyrrolate decreased frequency of medetomidine-associated adverse effects. (J Am Vet Med Assoc 1999;215:1116–1120)

Objective

To determine effects of low doses of medetomidine administered with and without butorphanol and glycopyrrolate to middle-aged and old dogs.

Design

Prospective randomized clinical trial.

Animals

88 healthy dogs ≥ 5 years old.

Procedure

Dogs were assigned randomly to receive medetomidine (2, 5, or 10 pa/kg [0.9, 2.3, or 4.6 μg/lb] of body weight, IM) alone or with glycopyrrolate (0.01 mg/kg [0.005 mg/Ib], SC), medetomidine (10 μg/kg) and butorphanol (0.2 mg/kg [0.1 mg/lb], IM), or medetomidine (10 μg/kg), butorphanol (0.2 mg/kg), and glycopyrrolate (0.01 mg/kg). Anesthesia was induced with thiopental sodium and maintained with isoflurane. Degree of sedation and analgesia were determined before and after medetomidine administration. Respiratory rate, heart rate, and mean arterial blood pressure were determined 10 and 30 minutes after medetomidine administration. Adverse effects and amounts of thiopental and isoflurane used were recorded.

Results

Sedation increased after medetomidine administration in 79 of 88 dogs, but decreased in 7 dogs that received 2 or 5 μg of medetomidine/kg. Mean postsedation analgesia score and amounts of thiopental and isoflurane used were less in dogs that received medetomidine and butorphanol, compared with other groups. Respiratory rate, heart rate, and blood pressure were not different among groups. Significantly more adverse effects developed in dogs that did not receive glycopyrrolate.

Conclusions and Clinical Relevance

Administration of medetomidine (10 μg/kg, IM) and butorphanol (0.2 mg/kg, IM) induced sedation and analgesia and reduced amounts of thiopental and isoflurane required for anesthesia in middle-aged and old dogs. Glycopyrrolate decreased frequency of medetomidine-associated adverse effects. (J Am Vet Med Assoc 1999;215:1116–1120)

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 276 276 55
PDF Downloads 36 36 2
Advertisement